Literature DB >> 23408358

Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.

Phillipp Hartmann1, Peng Chen, Hui J Wang, Lirui Wang, Declan F McCole, Katharina Brandl, Peter Stärkel, Clara Belzer, Claus Hellerbrand, Hidekazu Tsukamoto, Samuel B Ho, Bernd Schnabl.   

Abstract

UNLABELLED: The intestinal mucus layer protects the epithelium from noxious agents, viruses, and pathogenic bacteria present in the gastrointestinal tract. It is composed of mucins, predominantly mucin (Muc) 2, secreted by goblet cells of the intestine. Experimental alcoholic liver disease requires translocation of bacterial products across the intestinal barrier into the systemic circulation, which induces an inflammatory response in the liver and contributes to steatohepatitis. We investigated the roles of the intestinal mucus layer, and in particular Muc2, in development of experimental alcohol-associated liver disease in mice. We studied experimental alcohol-induced liver disease, induced by the Tsukamoto-French method (which involves continuous intragastric feeding of an isocaloric diet or alcohol) in wild-type and Muc2(-/-) mice. Muc2(-/-) mice showed less alcohol-induced liver injury and steatosis than developed in wild-type mice. Most notably, Muc2(-/-) mice had significantly lower plasma levels of lipopolysaccharide than wild-type mice after alcohol feeding. In contrast to wild-type mice, Muc2(-/-) mice were protected from alcohol-associated microbiome changes that are dependent on intestinal mucins. The antimicrobial proteins regenerating islet-derived 3 beta and gamma were expressed at significantly higher levels in the jejunum of Muc2(-/-) mice fed the isocaloric diet or alcohol compared with wild-type mice. Consequently, Muc2(-/-) mice showed increased killing of commensal bacteria and prevented intestinal bacterial overgrowth.
CONCLUSION: Muc2(-/-) mice are protected from intestinal bacterial overgrowth and dysbiosis in response to alcohol feeding. Subsequently, lower amounts of bacterial products such as endotoxin translocate into the systemic circulation, decreasing liver disease.
Copyright © 2013 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408358      PMCID: PMC3695050          DOI: 10.1002/hep.26321

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.

Authors:  Melissa A Kinnebrew; Charlie G Buffie; Gretchen E Diehl; Lauren A Zenewicz; Ingrid Leiner; Tobias M Hohl; Richard A Flavell; Dan R Littman; Eric G Pamer
Journal:  Immunity       Date:  2012-02-02       Impact factor: 31.745

2.  Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.

Authors:  M Fujimoto; M Uemura; Y Nakatani; S Tsujita; K Hoppo; T Tamagawa; H Kitano; M Kikukawa; T Ann; Y Ishii; H Kojima; S Sakurai; R Tanaka; T Namisaki; R Noguchi; T Higashino; E Kikuchi; K Nishimura; A Takaya; H Fukui
Journal:  Alcohol Clin Exp Res       Date:  2000-04       Impact factor: 3.455

Review 3.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease.

Authors:  Arthur W Yan; Derrick E Fouts; Johannes Brandl; Peter Stärkel; Manolito Torralba; Eckart Schott; Hide Tsukamoto; Karen E Nelson; David A Brenner; Bernd Schnabl
Journal:  Hepatology       Date:  2010-12-10       Impact factor: 17.425

5.  Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

Authors:  A Parlesak; C Schäfer; T Schütz; J C Bode; C Bode
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

Review 6.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

7.  Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients.

Authors:  Dae Won Jun; Kyung Tae Kim; Oh Young Lee; Jeong Don Chae; Byoung Kwan Son; Seong Hwan Kim; Yun Ju Jo; Young Sook Park
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

8.  The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine.

Authors:  Shipra Vaishnava; Miwako Yamamoto; Kari M Severson; Kelly A Ruhn; Xiaofei Yu; Omry Koren; Ruth Ley; Edward K Wakeland; Lora V Hooper
Journal:  Science       Date:  2011-10-14       Impact factor: 47.728

Review 9.  Microbes inside--from diversity to function: the case of Akkermansia.

Authors:  Clara Belzer; Willem M de Vos
Journal:  ISME J       Date:  2012-03-22       Impact factor: 10.302

10.  Immunohistochemical evidence of Muc1 expression during rat embryonic development.

Authors:  E Lacunza; V Ferretti; C Barbeito; A Segal-Eiras; M V Croce
Journal:  Eur J Histochem       Date:  2010-11-26       Impact factor: 3.188

View more
  94 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

3.  Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Authors:  Stephanie Mathews; Dechun Feng; Igor Maricic; Cynthia Ju; Vipin Kumar; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

4.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

5.  Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice.

Authors:  Sena Bluemel; Lirui Wang; Claire Kuelbs; Kelvin Moncera; Manolito Torralba; Harinder Singh; Derrick E Fouts; Bernd Schnabl
Journal:  Gut Microbes       Date:  2019-04-14

Review 6.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

Review 7.  Gut-liver axis at the frontier of host-microbial interactions.

Authors:  Katharina Brandl; Vipin Kumar; Lars Eckmann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-23       Impact factor: 4.052

8.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

9.  Microbiome-Immune Interactions and Liver Disease.

Authors:  James H Tabibian; Cyril Varghese; Steven P O'Hara; Nicholas F LaRusso
Journal:  Clin Liver Dis (Hoboken)       Date:  2015-05-07

10.  Maternal vitamin D beneficially programs metabolic, gut and bone health of mouse male offspring in an obesogenic environment.

Authors:  C R Villa; J Chen; B Wen; S M Sacco; A Taibi; W E Ward; E M Comelli
Journal:  Int J Obes (Lond)       Date:  2016-10-04       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.